Gilead Sciences Inc (GILD)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 7,605,000 | 7,330,000 | 9,918,000 | 4,071,000 | 4,287,000 |
| Revenue | US$ in thousands | 26,229,000 | 26,413,000 | 26,325,000 | 24,689,000 | 22,449,000 |
| Operating profit margin | 28.99% | 27.75% | 37.68% | 16.49% | 19.10% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $7,605,000K ÷ $26,229,000K
= 28.99%
The operating profit margin of Gilead Sciences, Inc. has shown fluctuations over the past five years. In 2019, the operating profit margin was at 19.10%, significantly lower than the subsequent years. There was a notable improvement in 2020 when the operating profit margin increased to 40.21%, reflecting increased efficiency in generating profits from operations. However, there was a slight decline in the operating profit margin in 2021 to 36.97%, followed by a further decrease in 2022 to 40.23%.
The most recent data for December 31, 2023, shows a notable decrease in the operating profit margin to 32.49%, indicating a decrease in profitability from operations compared to the previous year. This decline could be a result of various factors such as changes in revenue, expenses, or the overall efficiency of the company's operations.
Overall, while the operating profit margin has shown fluctuations, Gilead Sciences, Inc. has demonstrated the ability to generate profits from its core operations, although the recent decline in the margin warrants further analysis to understand the underlying reasons and implications for the company's financial performance.
Peer comparison
Dec 31, 2023